Veeru Kasi
veerukasi.bsky.social
Veeru Kasi
@veerukasi.bsky.social
Director @BURSTUrology | Hunterian Professor 2021 | Consultant Urologist & Associate Prof @UCL @UCLH | Ed Board @IJSSurgery @BJUIJournal @EUPlatinum | Man Utd
Reposted by Veeru Kasi
[9/9] 📖 If you would like to learn more about why this research is so important for men with #ProstateCancer, you can read more about the project in our latest News & Views article: buff.ly/3QrafUP
October 23, 2025 at 2:37 PM
Reposted by Veeru Kasi
[8/9] Impact:

🥳 bpMRI detects clinically significant #ProstateCancer as effectively as mpMRI, without increasing detection of insignificant cancer.

💙 Adopting bpMRI scans would increase scanner capacity and help more men receive timely diagnoses.
October 23, 2025 at 2:37 PM
Reposted by Veeru Kasi
[7/9] ✅ Importantly, the team also demonstrated that bpMRI and mpMRI detect a comparable number of clinically insignificant #ProstateCancer.

💙 This is crucial to minimise overdiagnosis and protect men from unnecessary biopsies.
October 23, 2025 at 2:37 PM
Reposted by Veeru Kasi
[6/9] ✅ Excitingly, the research showed that bpMRI is just as effective as mpMRI in detecting clinically significant #ProstateCancer.
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
[5/9] 👨 In the trial, 490 men underwent a scan.

🩻 Results for bpMRI were reviewed first, followed by those for mpMRI.

💉 If either scan indicated #ProstateCancer, men had a targeted biopsy.
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
[4/9] 💰 To explore this, we funded a clinical trial called PRIME, which investigated whether bpMRI is as effective as mpMRI in detecting clinically significant #ProstateCancer.
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
[3/9] 💡 The team proposed biparametric MRI (bpMRI) as a faster, effective alternative.

🩻 While mpMRI uses 3 imaging types, bpMRI uses 2 and doesn’t require contrast agents, cutting scan time by up to 50%, increasing capacity, removing the need for injections, and lowering costs.
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
[2/9] ️Multiparametric MRI (mpMRI) is now a key part of the diagnostic pathway for #ProstateCancer, thanks in part to research we supported in 2008.

👨 The next challenge: how can we make diagnostic imaging more efficient?
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
[1/9] 🔎 Let’s take a closer look at the exciting findings from the Prostate Cancer UK-funded study led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk recently published in @jama.com 🧵.
Prostate Cancer UK Professionals (@prostateukprofs.bsky.social)
Could faster MRI scans allow more men to receive timely #ProstateCancer diagnoses? Research published in @jama.com led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk compares the…
bsky.app
October 23, 2025 at 2:36 PM
Reposted by Veeru Kasi
Could faster MRI scans allow more men to receive timely #ProstateCancer diagnoses?

Research published in @jama.com led by @veerukasi.bsky.social, Dr Alex Ng & Dr Aqua Asif at @ucl.ac.uk compares the efficacy of shortened versus standard-length scans.

Grab a ☕ & read: doi.org/10.1001/jama...
September 16, 2025 at 4:15 PM
Reposted by Veeru Kasi
[7/8]
🤗And the @ucl.ac.uk @veerukasi.bsky.social teams showed supporters how their fundraising is enabling huge improvements to diagnosis and care.
June 18, 2025 at 10:07 AM
Reposted by Veeru Kasi
A huge thank you to all our collaborators for coming along to our #ELIPSE meeting @benchallacombe.bsky.social @veerukasi.bsky.social
May 22, 2025 at 1:04 PM
Reposted by Veeru Kasi
📢 LESS THAN ONE WEEK LEFT

"We welcome applications from a range of experience levels, from senior trainees to junior trainees to house officers or medical students"

- Mr @veerukasi.bsky.social, BURST Director

🗓️ Apply by Feb 28th: redcap.slms.ucl.ac.uk/surveys/?s=3...

#BURST10 #UroSoMe
February 23, 2025 at 9:35 AM